We’ll draw on tele-health technology to connect people beyond their walls. To treat young people where they are best to be treated – whether that’s in hospital, at school, with their family at home, or in their own bed.
Technology at its heart
The latest advances in medical technology will be harnessed to deliver the best care for children where they need it most.
We will embrace:
- Digital technologies, for example call systems which enable clinicians to respond more quickly to patients’ requests
- Artificial Intelligence, used to help with diagnostics
- Electronic Patient Records
- 3D printing
We will continually review best practice and seek peer reviews to ensure that we are at leading edge of productivity in the design of our hospital and in delivering medical care.
This is a world’s first hospital. A whole new way of thinking.
Cambridge Children’s will be the essence of a forward-looking, data-empowered modern hospital.
Across departments of the University of Cambridge, the NHS and the east of England GP practices, schools and community services, we will create a ‘living database’.
A database that is constantly evolving to follow a child’s development, providing real time information to show how our interventions are making a difference individually, to patient groups and the health system.
In time, our growing body of data has the potential to benefit all children, across the world.
We are uniquely placed to cross-reference genomic data with NHS patient records and other national records. Interrogation of this data will enable us to develop an increasingly accurate picture of genetic risk factors and to interrogate the data at a scale which will allow us to determine the best treatment protocol for any given child depending on their unique make-up and condition.
Over time we will establish how this can impact not only on health but also on life course trajectories. Cambridge has developed whole genome sequencing within the NHS to benefit faster diagnosis and improved clinical care for seriously ill children. Our ambition is to support expansion of this programme across the NHS, and as the basis for international collaboration.
Our location on Cambridge’s Biomedical Campus, co-located with our partners in life sciences, will also allow us to develop distinctive child-centred clinical trials, knowing as we do that treating children is not simply a question of scaling down standard adult treatments, ultimately enabling us to achieve high impact discovery and advances in clinical care, genomics and data science in an approach aligned directly with the Government’s Life Sciences Industrial Strategy.
Our ultimate goal is to prove that child-centred interventions are the best way to prevent physical and mental health conditions from ever occurring, setting the stage for a healthy life.